Source item
Open original source ↗This is interesting.
Moderna, $MRNA, is up more than 570% this year.
It's the 2nd-best stock in the S&P 500.
The stock jumped 140% in a single day in August after a late-stage melanoma trial came back positive. https://t.co/InoRbch2fE